JPH10273446A5 - - Google Patents

Info

Publication number
JPH10273446A5
JPH10273446A5 JP1997094989A JP9498997A JPH10273446A5 JP H10273446 A5 JPH10273446 A5 JP H10273446A5 JP 1997094989 A JP1997094989 A JP 1997094989A JP 9498997 A JP9498997 A JP 9498997A JP H10273446 A5 JPH10273446 A5 JP H10273446A5
Authority
JP
Japan
Prior art keywords
ala
lys
tcf
amino acid
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997094989A
Other languages
English (en)
Japanese (ja)
Other versions
JP3961064B2 (ja
JPH10273446A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP09498997A external-priority patent/JP3961064B2/ja
Priority to JP09498997A priority Critical patent/JP3961064B2/ja
Priority to CA002253929A priority patent/CA2253929A1/en
Priority to AU64208/98A priority patent/AU734794B2/en
Priority to US09/194,326 priority patent/US6306827B1/en
Priority to PCT/JP1998/001221 priority patent/WO1998043665A1/ja
Priority to EP98909799A priority patent/EP0925791A4/en
Priority to ZA982606A priority patent/ZA982606B/xx
Publication of JPH10273446A publication Critical patent/JPH10273446A/ja
Publication of JPH10273446A5 publication Critical patent/JPH10273446A5/ja
Publication of JP3961064B2 publication Critical patent/JP3961064B2/ja
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP09498997A 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤 Expired - Fee Related JP3961064B2 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP09498997A JP3961064B2 (ja) 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤
PCT/JP1998/001221 WO1998043665A1 (fr) 1997-03-28 1998-03-20 Agent preventif et/ou therapeutique pour les maladies des reins
AU64208/98A AU734794B2 (en) 1997-03-28 1998-03-20 Agent for preventing and/or treating renal disease
US09/194,326 US6306827B1 (en) 1997-03-28 1998-03-20 Method for preventing and/or treating renal disease
CA002253929A CA2253929A1 (en) 1997-03-28 1998-03-20 Preventive and/or therapeutic agent for kidney diseases
EP98909799A EP0925791A4 (en) 1997-03-28 1998-03-20 PREVENTIVE AND / OR THERAPEUTICALLY ACTIVE SUBSTANCE FOR KIDNEY DISEASES
ZA982606A ZA982606B (en) 1997-03-28 1998-03-27 Agent for preventing and/or treating renal disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP09498997A JP3961064B2 (ja) 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤

Publications (3)

Publication Number Publication Date
JPH10273446A JPH10273446A (ja) 1998-10-13
JPH10273446A5 true JPH10273446A5 (enExample) 2005-01-20
JP3961064B2 JP3961064B2 (ja) 2007-08-15

Family

ID=14125298

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09498997A Expired - Fee Related JP3961064B2 (ja) 1997-03-28 1997-03-28 腎疾患予防及び／又は治療剤

Country Status (7)

Country Link
US (1) US6306827B1 (enExample)
EP (1) EP0925791A4 (enExample)
JP (1) JP3961064B2 (enExample)
AU (1) AU734794B2 (enExample)
CA (1) CA2253929A1 (enExample)
WO (1) WO1998043665A1 (enExample)
ZA (1) ZA982606B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531673T2 (de) * 1994-12-27 2004-07-08 Daiichi Pharmaceutical Co., Ltd. Tcf mutante
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ES2274567T3 (es) 1997-03-14 2007-05-16 Daiichi Pharmaceutical Co., Ltd. Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
JP4252591B2 (ja) * 2006-08-08 2009-04-08 クロリンエンジニアズ株式会社 オゾン製造装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468400A (en) 1987-09-09 1989-03-14 Sapporo Breweries Human tumor cytotoxic factor htcf, production thereof and antitumor agent comprising said factor as active ingredient
JP3380573B2 (ja) * 1992-07-16 2003-02-24 第一製薬株式会社 Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
CA2100720C (en) * 1992-07-16 2003-03-11 Hiroaki Masunaga Medicinal composition comprising tcf-ii
DE69531673T2 (de) 1994-12-27 2004-07-08 Daiichi Pharmaceutical Co., Ltd. Tcf mutante

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
AR064896A2 (es) Composicion farmaceutica no higroscopica
GB9806632D0 (en) Peptide factor
EA199700233A1 (ru) Дозирующий ингалятор для салметерола
MA26842A1 (fr) Amino-acides bicycliques servant d'agents pharmaceutiques
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
CA2275717A1 (en) Chitosan-gelatin a microparticles
EP1574219A3 (en) Method of inhibiting fibrosis with a somatostatin agonist
NO317747B1 (no) Farmasoytisk preparat samt anvendelse derav
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
DE60036205D1 (de) Granulat bestehend aus Stärke und Laktose
FI20000720A7 (fi) Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
NZ505073A (en) Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases
HUP0001758A3 (en) Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus, pharmaceutical compositions comprising thereof and their use
CA2338794A1 (en) New oral formulation for 5-ht4 agonists or antagonists
WO2002004421A3 (en) Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
ZA9811445B (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
RU94046091A (ru) Полипептидные антагонисты бомбезина, фармацевтическая композиция и способ лечения
WO2003005880A3 (en) Replikin peptides and uses thereof
CA2388910A1 (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
JPH10273446A5 (enExample)
CA2217513A1 (en) Pharmaceutical agents for the treatment of alzheimer's disease
ITRM950273A0 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni farmaceutiche.
ITTO20000674A0 (it) Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca.